Keep pulling the thread on Shiv Rao.
Abridge's core strategy is to own the "signal" of the doctor-patient conversation, using automated note-taking as a wedge to expand into other workflows.
Goldman Sachs estimates that the adoption of AI agents will increase token consumption by 24 times within a five-year period.
Abridge raised a $300 million funding round approximately one year ago.
Shiv Rao believes the primary opportunity for AI in healthcare is to fundamentally change the industry's business models, not just to deploy new clinical technology.
OpenAI and Anthropic have announced partnerships with large private equity groups to deploy engineers into their portfolio companies.
Abridge raised an early funding round of $5 million at a $15 million pre-money valuation in the 2018-2019 timeframe.
Some doctors are reportedly refusing to join healthcare systems that do not provide Abridge's software.
Shiv Rao believes vertical AI companies must collaborate with and leverage foundation models to succeed, rather than competing directly against them.
Approximately 40% of the model outputs within Abridge's product are generated by its own in-house models.
Abridge's strategy is to use frontier AI models for complex healthcare use cases where continuous improvement is critical and perfection is unattainable.
Henry Kravis advised Shiv Rao that Abridge does not need to go public and should only consider it if necessary to achieve its mission.
In the United States healthcare system, physician compensation is based on documented care, not the care itself, making documentation a critical part of the revenue cycle.